Oral glucose tolerance testing in children with cystic fibrosis (Q37377703)

20 August 2017

Oral glucose tolerance testing in children with cystic fibrosis (English)

1 reference

20 August 2017

0 references

0 references

0 references

Brigitte Frohnert

2

0 references

Katie Larson Ode

object named as

Katie Larson Ode

1

0 references

Theresa A Laguna

object named as

Theresa Laguna

3

0 references

author name string

James Phillips

4

1 reference

20 August 2017

Bonnie Holme

5

1 reference

20 August 2017

Warren Regelmann

6

1 reference

20 August 2017

William Thomas

7

1 reference

20 August 2017

Antoinette Moran

8

1 reference

20 August 2017

1 November 2010

1 reference

20 August 2017

1 reference

20 August 2017

11

1 reference

20 August 2017

7

1 reference

20 August 2017

487-492

1 reference

Diabetes as a determinant of mortality in cystic fibrosis

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Management of cystic fibrosis-related diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Microvascular complications in cystic fibrosis-related diabetes.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Long-term effect of insulin treatment in cystic fibrosis-related diabetes

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3856892

Diabetes mellitus associated with cystic fibrosis

2 September 2018

1 reference

12 December 2020

Effects of tolbutamide on growth and body composition of nondiabetic children with cystic fibrosis

1 reference

12 December 2020

Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis

1 reference

12 December 2020

Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections

1 reference

12 December 2020

Epidemiology of cystic fibrosis-related diabetes

1 reference

12 December 2020

Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes?

1 reference

12 December 2020

Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance

1 reference

12 December 2020

10.1111/J.1399-5448.2009.00632.X

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

20202149

1 reference